MedTrace Logo

Effects of Amorphous Calcium Carbonate Supplementation on Bone Health in Postmenopausal Women With Osteopenia

NCT05810909 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2023-04-13

No results posted yet for this study

Summary

This research was designed in accordance to the Method for Efficacy Assessment of Health Food for Bone Heath. Changes to bone density were measured to evaluate the effectiveness of amorphous calcium carbonate in maintaining bone health.

Conditions

  • Calcium
  • Osteopenia
  • Bone Mineral Density
  • Bone Turnover Marker

Interventions

DIETARY_SUPPLEMENT

amorphous calcium carbonate/ Placebo

The dosage was 1000 mg calcium carbonate (400mg calcium element) per day, and placebo (calcium carbonate change to excipient)

Sponsors & Collaborators

  • Taipei Medical University

    collaborator OTHER

  • Universal Integrated Corp.

    lead INDUSTRY

Principal Investigators

  • Yi-Wen Chien, professor · Taipei Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-10
Primary Completion
2021-12-10
Completion
2022-09-22

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05810909 on ClinicalTrials.gov